Program Description This journal supplement will focus on the use of technology to proactively prevent medication errors. The estimate of 44,000 to 98,000 annual patient deaths due to adverse medical events (AMEs) is often quoted in the literature and prevention of medication errors continues to dominate the health-system quality improvement environment.
In tackling the medication error problem, high tech infusion technology is often considered, but requires planning to implement. Additionally, the data available from such technology is robust, but may be overwhelming. Without a clear strategy, the data may not reach its full potential to assist health professionals in improving patient care. Learning Objectives The target audience for this program is pharmacists and nurses in health-system settings. At the completion of this activity, the participants will be able to:
Describe the lessons learned from facilities that have implemented and are maintaining intelligent infusion technology
Outline the process of developing drug libraries, including drug libraries for specialty patient populations
Explain the use of data reports from intelligent infusion technology in improving compliance, medication administration practices and quality of care
Devise strategies for the clinician and administrator in using intelligent infusion technology to optimize patient care
Faculty/Funding
Burnis D. Breland, MS, PharmD, FASHP Director of Pharmacy Columbus Regional Healthcare System The Medical Center, Inc. Columbus, Georgia
Kelly A. Michienzi, PharmD Clinical Pharmacy Coordinator Women & Children’s Hospital of Buffalo Buffalo, New York
This program is supported by an educational grant from Hospira, Inc. Accreditation Pharmacists: ProCE, Inc is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number 221-000-09-013-H05-P has been assigned to this home-study program (initial release date 3-14-09). This program is acceptable for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued online at http://www.ProCE.com/ upon successful completion of the post-test (≥ 70% correct). No partial credit will be given.
Nurses: Nurse CE is provided for this journal supplement through collaboration between ProCE, Inc and Wild Iris Medical Education, Inc. Wild Iris Medical Education, WSNA CEARP Provider number PA-5/Feb/11, is an approved provider of continuing education by the Washington State Nurses Association, an accredited approver by the American Nurses' Credentialing Center's Commission on Accreditation. California Board of Registered Nursing Provider #12300. This activity provides 1.5 contact hours of nurse CE credit.
Faculty Disclosure It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Breland and Dr. Michienzi report serving as faculty for Hospira-funded educational programming.
Please note: The opinions expressed in this program should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
www.pppmag.com uses tracking technologies. The site may also
include cookies from third parties. By continuing to use this website, you consent
to the use of tracking technologies as defined in our
Privacy Policy that can be read by clicking here.
